Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 15/20 | 0.68 |
| ▸ | PPARG | P37231 | 13/20 | 0.68 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.58 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.58 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.58 |
| ▸ | CTSL | P07711 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL448537 | 0.84 | ADORA3 (0.67) | PPARDPPARGADORA3ADORA1ADORA2A | |
| SCHEMBL29703226 | 0.81 | PPARD (1.00) | PPARDPPARGADORA3ADORA1ADORA2A | |
| SCHEMBL29703229 | 0.81 | PPARD (1.00) | PPARDPPARGADORA3ADORA1ADORA2A | |
| SCHEMBL29703283 | 0.81 | PPARD (1.00) | PPARDPPARGADORA3ADORA1ADORA2A | |
| SCHEMBL29703230 | 0.79 | TDP1 (0.59) | PPARDPPARGADORA3ADORA1ADORA2A | |
| SCHEMBL29703212 | 0.79 | PPARG (1.00) | PPARDPPARGADORA3ADORA1ADORA2A | |
| SCHEMBL29703297 | 0.79 | PPARG (1.00) | PPARDPPARGADORA3ADORA1ADORA2A | |
| SCHEMBL27501567 | 0.79 | ADORA3 (0.69) | PPARDPPARGADORA3ADORA1ADORA2A | |
| SCHEMBL6820865 | 0.78 | PPARG (0.65) | PPARDPPARGADORA3ADORA1ADORA2A | |
| SCHEMBL5197254 | 0.77 | ADORA3 (0.67) | PPARDPPARGADORA3ADORA1ADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022124859-A1 | 1'-HOMOADENOSNE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HYPOADIPONECTINEMIA-ASSOCIATED DISEASES OR PSORIASIS, CONTAINING SAME AS ACTIVE INGREDIENT | 서울대학교산학협력단 | 2022-06-16 | — | — | WO | disclosed |